FindTrial
Sign In

A New Eating-Behavior Modification Program (BOOCS) Improves Glycemic Control, Treatment Satisfaction and Emotional Distress in Patients With Mild Type 2 Diabetes – A Randomized Controlled Trial

A New Eating-Behavior Modification Program (BOOCS) Improves Glycemic Control, Treatment Satisfaction and Emotional Distress in Patients With Mild Type 2 Diabetes – A Randomized Controlled Trial - BOOCS-program improves mild type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008648
Enrollment
63
Registered
2012-08-08
Start date
2001-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 Diabetes

Interventions

Sixty three out-patients with type 2 diabetes followed by diet therapy only (average HbA1c: 7.6%, BMI: 25.4kg/m2) were randomly divided into the standard-therapy group and BOOCS-therapy group, and we

Sponsors

Fukuoka Seishukai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (a) male or female, 30 years or older, (b) attending an education program on diabetes regarding the cause of the disease, process, complications, exercise therapy, and diet therapy by conventional calorie control, and visiting the hospital continuously for 6 months or more.

Exclusion criteria

Exclusion criteria: (a) not receiving pharmacologic treatment, such as an oral hypoglycemic agent or insulin, and treatment for 8 weeks prior to the start of the trial has only been diet therapy, and (b) without unstable diabetes complications, alcohol addiction, or mental illness.

Design outcomes

Primary

MeasureTime frame
HbA1c, blood glucose, IRI,serum lipids, Body weight,DTSQ, PAID—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026